Researchers from all around the United States have been awarded significant money in order to try out novel mRNA vaccination systems on a variety of creatures. These organisms include rats, cattle, and crops.
In spite of the risks involved with the mRNA platform and the fact that it has not been successful in human populations, the government is continuing to finance additional mRNA trials in an effort to genetically modify humans, animals, and food.
Injections of mRNA into animals, such as cattle, chicken, and pigs, as well as injections into vegetables, are now the subject of research and experimentation by scientists.
At this time, there are no rules that are in place to safeguard the food supply or the human genome from the potential repercussions of mRNA research. These potential repercussions include the widespread development and use of biological weapons within animals and produce.
Experimentation with mRNA is still being carried out at a number of different locations, including Iowa State University.
experiments of an mRNA vaccination system are now being carried out on cows by the Veterinary Microbiology and Preventive Medicine Department. These experiments are being carried out with the intention of eliciting immunological protection in cows who are vulnerable to RSV infection. Through the use of a vaccination implant, the prefusion F mRNA is constantly administered as part of the vaccine platform. The implant delivers mRNA that has been pre-programmed into the cells of the cow, which instructs those cells to make a pathogenic protein antigen that the cow’s immune cells are then trained to target.
The technology will initially be tested on mice before it is considered a “cost-effective way” to sustain cow numbers. This testing will be done before the technology is offered to the public.
The National Cattlemen’s Beef Association made the announcement on April 5, 2023, that there are no mRNA vaccines that have been granted approval for use in beef cattle in the United States at the present time. Even though cattle farmers and ranchers routinely vaccinate their animals to protect them from and treat a variety of diseases, none of these vaccinations use mRNA technology.
The group gives the impression that it is worried about the possibility that mRNA research may be incorporated into the supply of cattle.
Both Merck and Genvax are competing to be the company that will inject mRNA into pigs. Pork farmers have already begun re-engineering pig cells using Merck’s Sequivity platform in order to express a number of porcine illnesses, including swine flu. Among these diseases is also the African swine fever.
Pigs that consume this mRNA platform mass end up producing poisons, and their immune cells are coerced into developing responses that are particular to alien bioweapon proteins. On top of that, this mRNA platform has not shown any special benefits to hog populations, and sow death rates have increased from 11.1% in 2017 to 12.6% in 2021. This makes a bad situation much worse. The mRNA platform has not solved the issues that have been plaguing the pig business, and it may potentially expedite the long-term demise of hog populations since the immune systems of the animals will become dependent on the programming of the mRNA from one season to the next.
In an effort to stay competitive in the battle to introduce mRNA bioweapons into the food chain, Genvax Technologies is working on a self-amplifying mRNA vaccination that will be administered to animal herds.
In addition to receiving grants from the USDA-Agricultural Research Services Plum Island Animal Disease Center and the Foundation for Food and Agriculture Research, the startup company has been successful in raising a total of $6.5 million in funding from United Animal Health, Johnsonville Ventures, the Iowa Corn Growers Association, the Summit Agricultural Group, and the Ag Startup Engine. The mRNA platform is being pushed as a way to tackle both present dangers to the food supply chain as well as emerging threats to the chain. The mRNA will instruct the pigs to manufacture proteins that are modeled after different strains of African swine disease. When a new outbreak of the disease is discovered, the mRNA platform will be used to modify cattle cells so that they can mount an immune response that is unique to the mutation. The animals will be altered with a transgene or a “gene of interest” that is designed to match the most common variant strain that is currently circulating.
The freedom of speech and alternative media face challenges from powerful entities. Real Raw News relies on reader support to flourish and endure.
We invest extensive time in verifying, researching, and crafting our work. Your contribution matters greatly. Every dollar aids in maintaining the site's vitality and assists the author, including covering medical expenses. https://gogetfunding.com/realnewscast/